Seeking Alpha

United Therapeutics (UTHR -0.7%) says its wholly owned subsidiary, United Therapeutics Europe,...

United Therapeutics (UTHR -0.7%) says its wholly owned subsidiary, United Therapeutics Europe, has received approval from French regulators for its New Drug Application for Intravenous Remodulin for the treatment of pulmonary arterial hypertension.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|